Obsidian Therapeutics Inc. Company Profile
NASDAQ: OBXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Obsidian Therapeutics at a glance
Obsidian Therapeutics Inc. (NASDAQ: OBX) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Cambridge, MA. Obsidian Therapeutics is led by Dr. Madan Jagasia M.D., M.S. and employs about 87 people. At a market capitalization of $816.6 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0002130606, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Obsidian Therapeutics do?
Obsidian Therapeutics, Inc. operates as a clinical-stage biotechnology company developing engineered cell and gene therapies. The company is developing investigational therapies, including OBX-115, which is being evaluated in clinical trials for advanced solid tumors, advanced melanoma, and relapsed refractory non-small cell lung cancer. It utilizes a proprietary Cytodriver technology platform designed to regulate protein function using FDA-approved small-molecule drugs and is advancing tumor-infiltrating lymphocyte (TIL) cell therapies that leverage mbIL15 to enhance persistence, antitumor activity, and clinical safety. Access to investigational therapies is currently limited to participation in clinical trials, and the company collaborates with other organizations to apply its platform technology. The company was founded in 2015 and is based in Cambridge, Massachusetts.
Business description based on the company's public filings.
Company information
- Legal name
- Obsidian Therapeutics Inc.
- Ticker
- NASDAQ: OBX
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Dr. Madan Jagasia M.D., M.S.
- Employees
- 87
- Headquarters
- 1030 Massachusetts Avenue, Cambridge, MA, United States
- Phone
- (781) 806-6245
- Website
- obsidiantx.com
- Market cap
- $816.64M
- SEC CIK
- 0002130606
Companies similar to Obsidian Therapeutics
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| AVBPArriVent BioPharma Inc. | 16.89 | +11.93% | $832.81M | vs OBX |
| IVAInventiva S.A. American Depository Shares | 3.37 | -2.75% | $794.88M | vs OBX |
| ARDXArdelyx Inc. | 3.26 | -1.51% | $841.69M | vs OBX |
| IMMXImmix Biopharma Inc. | 9.49 | -1.56% | $786.75M | vs OBX |
| LXRXLexicon Pharmaceuticals Inc. | 1.76 | +0.57% | $783.12M | vs OBX |
| GERNGeron Corporation | 1.20 | -0.83% | $770.97M | vs OBX |
| HELPHelus Pharma Inc. | 10.51 | -2.32% | $767.86M | vs OBX |
| ANNXAnnexon Inc. | 4.01 | -0.50% | $760.21M | vs OBX |